Chylomicron News and Research

RSS
Familial Chylomicronemia Syndrome: How HCP’s can Support Patients with Rare Diseases

Familial Chylomicronemia Syndrome: How HCP’s can Support Patients with Rare Diseases

Study provides new insight into complex interchange that can raise blood levels of fat in type 1 diabetes

Study provides new insight into complex interchange that can raise blood levels of fat in type 1 diabetes

Akcea Therapeutics obtains FDA Orphan Drug Designation for volanesorsen

Akcea Therapeutics obtains FDA Orphan Drug Designation for volanesorsen

Researchers explore association between vitamin A and neonatal health

Researchers explore association between vitamin A and neonatal health

Isis Pharmaceuticals reports pro forma net operating loss of $22.6 million for Q1 2014

Isis Pharmaceuticals reports pro forma net operating loss of $22.6 million for Q1 2014

Isis Pharmaceuticals reports final data from ISIS-APOCIIIRx Phase 2 study in patients with FCS

Isis Pharmaceuticals reports final data from ISIS-APOCIIIRx Phase 2 study in patients with FCS

Scientist receives grant to study biochemical fate of nanoemulsion-based food delivery systems in GI tract

Scientist receives grant to study biochemical fate of nanoemulsion-based food delivery systems in GI tract

ApoA-V as a contributor to dyslipidemia in obese children

ApoA-V as a contributor to dyslipidemia in obese children

LPL deficiency treatment poised to be first gene therapy in Europe

LPL deficiency treatment poised to be first gene therapy in Europe

Gene therapy improves chylomicron metabolism in LPLD patients

Gene therapy improves chylomicron metabolism in LPLD patients

AMT total net loss decreases 7% to € 8.7 million for first half year of 2011

AMT total net loss decreases 7% to € 8.7 million for first half year of 2011

AMT receives CHMP opinion on Glybera Marketing Authorisation Application

AMT receives CHMP opinion on Glybera Marketing Authorisation Application

AMT presents long-term efficacy study of Glybera in treatment of lipoprotein lipase deficiency

AMT presents long-term efficacy study of Glybera in treatment of lipoprotein lipase deficiency

Angptl4 protein deficiency could promote inflammatory response in people who consume high saturated fat

Angptl4 protein deficiency could promote inflammatory response in people who consume high saturated fat

Tocotrienols can help reduce triglyceride levels

Tocotrienols can help reduce triglyceride levels

Amsterdam Molecular first half 2010 net loss in line with last year

Amsterdam Molecular first half 2010 net loss in line with last year

Amsterdam Molecular Therapeutics commences preregistration trial for Glybera

Amsterdam Molecular Therapeutics commences preregistration trial for Glybera

Fat-free diet reduces liver fat in fat-free mice

Fat-free diet reduces liver fat in fat-free mice

Not all trans fats are bad for you

Not all trans fats are bad for you

Protein CD36 may be important to future weight-loss strategies

Protein CD36 may be important to future weight-loss strategies